Drug Suits Raise Questions for Doctors and Juries

Judith Graves developed the medical condition known as jawbone death after taking the Merck’s osteoporosis drug Fosamax. She required five major operations, and she is now suing Merck.

Merck has argued that Fosamax is not the cause, and has pointed out that Graves took other prescriptions that weakened her immune system. The results of the lawsuit could affect litigation involving somewhere around 1,400 people across the U.S. who developed jawbone ailments after taking Fosamax.

According to the New York Times:

“In Mrs. Graves’s case, the trial is providing a palpable backdrop for a broadening debate among many doctors and researchers who are rethinking Fosamax and similar bone medications known as oral bisphosphonates, particularly as a treatment for women who have not yet developed osteoporosis.”

+ Sources and References
Post your comment
Click Here and be the first to comment on this article